The study provides genetic evidence that the insulin/insulin-like growth factor 1 (IGF1) ablation could be exploited therapeutically to treat lung cancer
New metabolic approach efficient against lung cancer - short science news - health news

Lung cancer is difficult to stop and is responsible for many deaths. Now, a new study suggests that 1 in 4 cases could be treated using a new approach. The new method uses a combined process: delivery of conventional drugs (IGF-1 inhibitors) together with a genetic approach to completely block insulin/IGF-1 signaling. This messes up the metabolism of the cancer cells and it worked beautifully with lab animals, with almost no tumors at 10 to 15 weeks. However, it remains to see how feasible it will be to apply this approach to treat humans.

Read the full story: ScienceDaily
Scientific publication: PNAS